Karen K. Biron

6.6k total citations
76 papers, 4.9k citations indexed

About

Karen K. Biron is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Karen K. Biron has authored 76 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Epidemiology, 18 papers in Immunology and 17 papers in Oncology. Recurrent topics in Karen K. Biron's work include Herpesvirus Infections and Treatments (52 papers), Cytomegalovirus and herpesvirus research (48 papers) and Virus-based gene therapy research (15 papers). Karen K. Biron is often cited by papers focused on Herpesvirus Infections and Treatments (52 papers), Cytomegalovirus and herpesvirus research (48 papers) and Virus-based gene therapy research (15 papers). Karen K. Biron collaborates with scholars based in United States, Italy and Poland. Karen K. Biron's co-authors include Sylvia C. Stanat, Christine L. Talarico, Alejo Erice, Gertrude B. Elion, John C. Drach, Leroy B. Townsend, Donald M. Coen, M. Colin Jordan, Anjalie Field and Sunwen Chou and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Clinical Microbiology Reviews.

In The Last Decade

Karen K. Biron

76 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen K. Biron United States 40 4.3k 1.2k 784 765 620 76 4.9k
James R. Beadle United States 28 1.4k 0.3× 290 0.2× 693 0.9× 835 1.1× 158 0.3× 88 2.5k
Carlos López United States 21 1.6k 0.4× 496 0.4× 152 0.2× 629 0.8× 125 0.2× 53 2.6k
Robert T. Sarisky United States 33 1.5k 0.4× 446 0.4× 259 0.3× 561 0.7× 91 0.1× 65 3.0k
Lbachir BenMohamed United States 44 2.4k 0.6× 248 0.2× 530 0.7× 380 0.5× 149 0.2× 134 4.7k
Sigvard Olofsson Sweden 39 2.1k 0.5× 223 0.2× 936 1.2× 921 1.2× 80 0.1× 123 4.2k
Phillip A. Furman United States 34 2.7k 0.6× 387 0.3× 713 0.9× 2.3k 3.0× 54 0.1× 73 5.3k
J Descamps Belgium 23 1.2k 0.3× 276 0.2× 184 0.2× 590 0.8× 69 0.1× 59 2.5k
P A Furman United States 29 2.4k 0.6× 545 0.5× 2.3k 2.9× 3.1k 4.0× 68 0.1× 44 5.7k
Bo Öberg Sweden 28 1.1k 0.2× 307 0.3× 745 1.0× 1.2k 1.6× 61 0.1× 76 2.8k
Pia Hartmann Germany 26 651 0.2× 269 0.2× 239 0.3× 562 0.7× 306 0.5× 76 1.9k

Countries citing papers authored by Karen K. Biron

Since Specialization
Citations

This map shows the geographic impact of Karen K. Biron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen K. Biron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen K. Biron more than expected).

Fields of papers citing papers by Karen K. Biron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen K. Biron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen K. Biron. The network helps show where Karen K. Biron may publish in the future.

Co-authorship network of co-authors of Karen K. Biron

This figure shows the co-authorship network connecting the top 25 collaborators of Karen K. Biron. A scholar is included among the top collaborators of Karen K. Biron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen K. Biron. Karen K. Biron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harvey, Richard J., Kevin Brown, Qin Zhang, et al.. (2009). GSK983: A novel compound with broad-spectrum antiviral activity. Antiviral Research. 82(1). 1–11. 52 indexed citations
2.
Biron, Karen K.. (2006). Antiviral drugs for cytomegalovirus diseases. Antiviral Research. 71(2-3). 154–163. 352 indexed citations
3.
Chou, Sunwen, et al.. (2004). Mutations in the Human Cytomegalovirus UL27 Gene That Confer Resistance to Maribavir. Journal of Virology. 78(13). 7124–7130. 62 indexed citations
4.
Selleseth, Dean W., Christine L. Talarico, Teresa Miller, et al.. (2003). Interactions of 1263W94 with Other Antiviral Agents in Inhibition of Human Cytomegalovirus Replication. Antimicrobial Agents and Chemotherapy. 47(4). 1468–1471. 31 indexed citations
5.
Biron, Karen K., Richard J. Harvey, Steven S. Good, et al.. (2002). Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l -Riboside with a Unique Mode of Action. Antimicrobial Agents and Chemotherapy. 46(8). 2365–2372. 295 indexed citations
6.
7.
Landry, Marie L., Sylvia C. Stanat, Karen K. Biron, et al.. (2000). A Standardized Plaque Reduction Assay for Determination of Drug Susceptibilities of Cytomegalovirus Clinical Isolates. Antimicrobial Agents and Chemotherapy. 44(3). 688–692. 112 indexed citations
8.
Zacny, Valerie, Edward Gershburg, Michelle G. Davis, Karen K. Biron, & Joseph S. Pagano. (1999). Inhibition of Epstein-Barr Virus Replication by a Benzimidazole l -Riboside: Novel Antiviral Mechanism of 5,6-Dichloro-2-(Isopropylamino)-1-β- l -Ribofuranosyl-1H-Benzimidazole. Journal of Virology. 73(9). 7271–7277. 60 indexed citations
9.
Townsend, Leroy B., Kristjan S. Gudmundsson, Susan M. Daluge, et al.. (1999). Studies Designed to Increase the Stability and Antiviral Activity (HCMV) of the Active Benzimidazole Nucleoside, TCRB. Nucleosides and Nucleotides. 18(4-5). 509–519. 27 indexed citations
10.
Biron, Karen K.. (1996). Cytomegalovirus: Genetics of Drug Resistance. Advances in experimental medicine and biology. 394. 135–143. 9 indexed citations
11.
Preheim, Laurel C., et al.. (1995). Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrobial Agents and Chemotherapy. 39(5). 1204–1205. 77 indexed citations
12.
Kimberlin, David W., Stephen E. Straus, Karen K. Biron, et al.. (1995). Antiviral resistance in clinical practice. Antiviral Research. 26(4). 423–438. 22 indexed citations
13.
Chamberlain, Stanley D., Karen K. Biron, Ronna E. Dornsife, et al.. (1994). An Enantiospecific Synthesis of the Human Cytomegalovirus Antiviral Agent [(R)-3-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic Acid. Journal of Medicinal Chemistry. 37(9). 1371–1377. 21 indexed citations
14.
Jacobson, Mark Z., T G Berger, Paul Becherer, et al.. (1990). Acyclovir‐resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). International Journal of Gynecology & Obstetrics. 33(1). 82–82. 13 indexed citations
15.
Erice, Alejo, Sunwen Chou, Karen K. Biron, et al.. (1989). Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised Patients. New England Journal of Medicine. 320(5). 289–293. 334 indexed citations
16.
Sawyer, M. H., Geneviève Inchauspé, Karen K. Biron, et al.. (1988). Molecular Analysis of the Pyrimidine Deoxyribonucleoside Kinase Gene of Wild-type and Acyclovir-resistant Strains of Varicella-Zoster Virus. Journal of General Virology. 69(10). 2585–2593. 51 indexed citations
17.
Spector, Thomas, Jacqueline Stonehuerner, Karen K. Biron, & D R Averett. (1987). Ribonucleotide reductase induced by varicella zoster virus. Biochemical Pharmacology. 36(24). 4341–4346. 24 indexed citations
18.
Biron, Karen K. & Gertrude B. Elion. (1982). Effect of acyclovir combined with other antiherpetic agents on varicella zoster virus in vitro. The American Journal of Medicine. 73(1). 54–57. 19 indexed citations
19.
Biron, Karen K. & Gertrude B. Elion. (1980). In vitro susceptibility of varicella-zoster virus to acyclovir. Antimicrobial Agents and Chemotherapy. 18(3). 443–447. 176 indexed citations
20.
Biron, Karen K., et al.. (1978). Adenovirus type 12 tumor antigen I. Separation from DNA polymerase α and immunoprecipitation of tumor-antigen polypeptides. Virology. 85(2). 464–474. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James R. Beadle Breakdown of academic impact, for papers by Carlos López Breakdown of academic impact, for papers by Robert T. Sarisky Breakdown of academic impact, for papers by Lbachir BenMohamed Breakdown of academic impact, for papers by Sigvard Olofsson Breakdown of academic impact, for papers by Phillip A. Furman Breakdown of academic impact, for papers by J Descamps Breakdown of academic impact, for papers by P A Furman Breakdown of academic impact, for papers by Bo Öberg Breakdown of academic impact, for papers by Pia Hartmann
Rankless by CCL
2026